By Sabela Ojea
Shares of Talaris Therapeutics on Friday climbed 5.2% to $2.70 in after-hours trading after it declared a special dividend.
The biotechnology company said the special payout to shareholders, to be paid in cash, is expected to be $1.51 per share. It is conditional upon closing its merger deal with Tourmaline Bio.
Talaris Therapeutics signed a deal with the healthcare services company on June 22.
The board will vote in favor or against the merger on Oct. 17.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
October 06, 2023 17:57 ET (21:57 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.